Tazido 200mg Tablet 6s

Tazido 200mg Tablet 6s is an antibiotic used to treat serious skin and soft tissue infections, including those caused by methicillin‑resistant Staphylococcus aureus (MRSA). It belongs to a group of medicines called oxazolidinones, which act by stopping bacteria from making essential proteins they need to grow. This medicine is usually prescribed as a short, once‑daily course, most often for 6 days, and is available for both oral and intravenous use. It is generally reserved for infections where other commonly used antibiotics may not be suitable or effective.

Tazido 200mg Tablet 6s is a prodrug, which means it is converted in the body to its active form, tedizolid, after you take it. Once converted, tedizolid works against many Gram‑positive bacteria, including MRSA and certain strains that are resistant to other antibiotics such as linezolid. Because of its strong activity, good oral absorption, and long half‑life, it can be given once a day, usually for a shorter duration than some older antibiotics used for similar infections.

Doctors typically prescribe Tazido 200mg Tablet 6s for acute bacterial skin and skin structure infections (ABSSSI) in adults and in children above a certain weight threshold. It can be started as an intravenous infusion in a hospital and then switched to tablets once the patient is stable, without changing the dose. Most people tolerate this medicine well, but like all antibiotics, it can cause side effects and must be used exactly as directed to reduce the risk of resistance and complications such as severe antibiotic‑associated diarrhoea.

Acute bacterial skin and skin structure infections (ABSSSI)

Used to treat moderate to severe skin infections such as cellulitis, wound infections, or major abscesses caused by susceptible bacteria, including MRSA.

Infections due to MRSA and other resistant Gram‑positive bacteria

Considered when infections are known or strongly suspected to be caused by resistant organisms, where other options may not work well.

Step‑down therapy from hospital to home

May be used to continue treatment as tablets after initial intravenous therapy in the hospital, helping shorten hospital stay while maintaining effective antibiotic coverage.

• Once‑daily dosing: A single daily dose makes it easier for patients to adhere to treatment, which is important for the successful cure of the infection.

• Short treatment course: Typically prescribed for 6 days, which is shorter than many other antibiotics used for similar infections, potentially reducing exposure and side‑effect risk.

• Good coverage against resistant bacteria: Active against MRSA and some strains resistant to older oxazolidinones, offering an option when common antibiotics may fail.

• High oral bioavailability: Tablets provide blood levels similar to the intravenous form, allowing a smooth switch from IV to oral therapy without a dose change.

• Generally well tolerated: In clinical studies, rates of some serious blood and nerve toxicities seen with longer‑course oxazolidinones appear lower with short‑course tedizolid, though caution is still needed.

While many people take Tazido 200mg Tablet 6s without major problems, some side effects can occur. Inform your doctor if any symptoms bother you or do not improve.

Common side effects

• Nausea or vomiting: You may feel sick to your stomach or vomit, especially during the first few doses. Taking the tablet with food may help.

• Diarrhoea: Loose or frequent stools are relatively common; however, very severe or bloody diarrhoea needs urgent attention.

• Headache: A mild to moderate headache can occur during treatment.

• Dizziness: Some patients feel light‑headed or dizzy, so care is needed when standing up quickly or driving.

Uncommon side effects

• Abdominal pain or cramps: Stomach discomfort or cramping may occur along with other digestive symptoms.

• Rash or itching: Skin redness, itching, or mild rash can be a sign of sensitivity to the drug.

• Changes in blood counts: Mild decreases in white blood cells, red blood cells, or platelets may occur, especially with prolonged or repeated courses, and may be picked up on blood tests.

• Visual disturbance or eye discomfort: Blurred or double vision, eye strain, or sensitivity to light have been reported.

Serious side effects (Require immediate medical attention)

• Severe, persistent diarrhoea: Watery or bloody stools with stomach cramps, with or without fever, may suggest a serious bowel infection such as C. difficile‑associated diarrhoea.

• Allergic reaction: Swelling of the face, lips, tongue, or throat, trouble breathing, widespread rash, or hives require emergency care.

• Nerve problems: Numbness, tingling, burning, or pain in the hands or feet, or vision changes, can indicate nerve toxicity and should be reported promptly.

• Unusual bruising or bleeding: Easy bruising, nosebleeds, gum bleeding, or blood in urine or stools can indicate effects on blood cells or clotting.

Take Tazido 200mg Tablet 6s exactly as prescribed by your doctor. The usual adult dose for skin infections is 200 mg once a day for 6 days, but only your doctor can decide what is right for you. You can take the tablet with or without food, at roughly the same time each day, to maintain steady levels in your body. Swallow the tablet whole with water.

Complete the full course, even if you start to feel better before the last dose, because stopping early can allow the infection to come back and increase the risk of antibiotic resistance. If you vomit soon after a dose and are unsure whether the tablet was absorbed, contact your doctor for advice rather than taking an extra tablet on your own.

• Use this antibiotic only for the prescribed infection and avoid sharing it with others, even if their symptoms seem similar.

• If you develop severe diarrhoea during or after treatment, do not self‑treat with anti‑diarrhoeal medicines; contact your doctor to rule out serious bowel infection.

• Tell your doctor if you have a history of blood disorders, vision problems, or nerve issues, as oxazolidinones, especially with repeated or prolonged use, can occasionally affect blood counts and nerves.

• Because tedizolid is usually given as a short 6‑day course, do not extend treatment on your own; any decision to continue or repeat a course should be made by your doctor.

• Keep a list of all medicines you are taking, including over‑the‑counter drugs and herbal supplements, and show it to every healthcare provider who treats you while you are on tedizolid.

• General food intake (MILD): Food does not significantly change how much tedizolid your body absorbs, so it can be taken with meals or on an empty stomach; taking it with food may help reduce nausea in some patients.

• Probiotic or fermented foods (MILD): Yogurt and other fermented foods are generally safe and may support gut health during antibiotic therapy, though they do not replace medical treatment.

• Other antibiotics and myelosuppressive drugs (MODERATE): Combining tedizolid with medicines that affect bone marrow (for example, some chemotherapy drugs) may increase the risk of low blood counts and may require more frequent monitoring.

• Serotonergic drugs (POTENTIAL MODERATE): Although tedizolid appears to have less monoamine oxidase (MAO) inhibition than linezolid, caution is still advised with medicines that affect serotonin (such as certain antidepressants), and patients should be monitored for symptoms like agitation, confusion, or sweating.

• Blood‑thinning medicines (MODERATE): Serious infection and antibiotic therapy can alter how blood thinners such as warfarin work; your doctor may recommend closer INR or clotting monitoring while you are being treated.

• Other medicines causing dizziness or blood‑pressure changes (MILD to MODERATE): Combining tedizolid with drugs that also cause dizziness or affect blood pressure can increase the risk of feeling light‑headed; report any severe symptoms to your doctor.

• Pre‑existing blood disorders (SEVERE): Patients with low blood counts or bone marrow problems need careful monitoring, as oxazolidinones can occasionally worsen cytopenias, particularly if treatment is prolonged.

• Peripheral neuropathy or optic neuropathy (MODERATE to SEVERE): Those with existing nerve or vision problems should be monitored closely for worsening symptoms, especially if repeated courses are needed.

• Severe liver impairment (MODERATE): Because the drug is mainly eliminated by the liver, patients with significant liver disease may have altered drug handling and require specialist oversight.

If you miss a dose, take it as soon as you remember on the same day. If it is nearly time for your next scheduled dose, skip the missed dose and take the next one at the regular time. Do not take two doses at once or extra doses to make up for the one you missed, as this may increase the risk of side effects without improving your infection. If you miss more than one dose, contact your doctor to discuss whether your treatment course needs to be adjusted.